corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 17461

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Electronic Source

Silverman E
NIH Suspends Big Grant To Emory University
Pharmalot 2008 Oct 14
http://www.pharmalot.com/2008/10/nih-suspends-big-grant-to-emory-university/


Full text:

The NIH has frozen a $9.3 million, five-year grant to Emory University in response to an investigation by the US Senate Finance Committee into alleged conflicts of interest among academic researchers who receive government grants and also do work for drugmakers (this is the grant).
The move, which was first reported by The Atlanta Journal-Constitution, comes after Charles Nemeroff (pictured left) stepped down as chair of the Emory psychiatry department. Nemeroff is being investigated for earning more than $2.8 million in consulting arrangements with various drugmakers between 2000 and 2007, but failed to report at least $1.2 million of this income to the university.
At issue is whether universities are adequately policing disclosures in an effort to maintain scientific integrity and objectivity. Under Nemeroff’s leadership, the paper reports that Emory’s psychiatry department pulled in more than $22 million in NIH grants just last year. But he has also drawn criticism for speaking and consulting fees paid by drugmakers whose products he has reviewed or promoted. The NIH has granted Emory more than $251 million in funding this year, 61 percent of its total research funds from outside sponsors, according to the paper.
The NIH grant that was frozen was awarded to Emory’s Centers for Intervention Development and Applied Research, and was exploring which factors make common treatments for depression succeed, the AJC writes. Researchers have received funding for two years of the grant, which started in July 2006, Emory tells the paper. Nemeroff’s colleague, Dr. Helen S. Mayberg, is now listed as principal investigator on the NIH grant that has been stalled.
Over the last several days, Emory has been informing faculty of new requirements for filling out disclosure forms, after the NIH required all Emory faculty to disclose any potential conflict of interest (back story). And today, Emory created a new university-wide central office to oversee administration and enforcement of conflict-of-interest policies.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909